Mason Chilmonczyk, Ph.D.
Chief Executive Officer, Co-founder
Andson Biotech

Jim West III, MS
Associate Director
BioTools Innovator

REGISTER HERE to participate via Zoom

REGISTER HERE to attend in-person.

Mason Chilmonczyk BIO
Mason developed the DynaCHIP technology for his Ph.D. dissertation at the Georgia Institute of Technology under Andrei G. Fedorov, Ph.D. During his postdoc, Mason served as the entrepreneurial and technical lead for the project, securing Biolocity and Georgia Research Alliance funding to support the development of the technology.

‍Mason formally cofounded Andson Biotech with Andrei just before it was backed by the well-known accelerator, Ycombinator, for their Winter 2022 batch. Under Mason's leadership, Andson was selected into Merck Pharmaceutical's inaugural accelerator program, the Merck Digital Sciences Studio (2022-2023), as well as the prestigious BioTools Innovator program (2023), where Andson was selected as a top 4 finalist.

Mason has served as a consultant on projects ranging from artificial intelligence cancer diagnosis to resonance-based diagnostics sensors. Before starting his PhD, Mason worked in hands on roles that have benefitted him tremendously as an engineer including a position at a sheet metal/frame shop and as a design engineer for a pharmaceutical packaging company.

Jim West BIO
I was fortunate enough to be in the first cohort of BioTools Innovator (BTI) in 2021, and now I'm working with the program to improve human health by accelerating the growth of a broad spectrum of life science tools, platform technologies, and diagnostics startups.

Powered by MedTech Innovator, the largest life science accelerator in the world, BTI is the first-ever accelerator for life science tools and research-enabling technologies. Leveraging the successful model of our flagship programs, our accelerator curates mentorships with industry experts and innovative early-stage biotechnology startups, and creates an immersive educational program to support founders. We foster collaborations by providing access to a global community of investors, strategic partners, and founders. BTI startups compete for up to $300k in non-dilutive cash prize funding.

*Lunch provided for in-person attendees, while supplies last